nodes	percent_of_prediction	percent_of_DWPC	metapath
Tafluprost—PTGS2—rheumatoid arthritis	0.454	1	CbGaD
Tafluprost—PTGS2—Sulfasalazine—rheumatoid arthritis	0.134	0.298	CbGbCtD
Tafluprost—PTGS2—Triamcinolone—rheumatoid arthritis	0.134	0.298	CbGbCtD
Tafluprost—PTGS2—Betamethasone—rheumatoid arthritis	0.115	0.256	CbGbCtD
Tafluprost—PTGS2—Dexamethasone—rheumatoid arthritis	0.0668	0.149	CbGbCtD
Tafluprost—Uveitis—Azathioprine—rheumatoid arthritis	0.00156	0.0727	CcSEcCtD
Tafluprost—Conjunctival hyperaemia—Cyclosporine—rheumatoid arthritis	0.000902	0.0421	CcSEcCtD
Tafluprost—PTGS2—Fluocinonide—Methylprednisolone—rheumatoid arthritis	0.000822	0.159	CbGdCrCtD
Tafluprost—Conjunctival hyperaemia—Prednisolone—rheumatoid arthritis	0.000821	0.0383	CcSEcCtD
Tafluprost—PTGS2—Fluocinonide—Dexamethasone—rheumatoid arthritis	0.000809	0.156	CbGdCrCtD
Tafluprost—PTGS2—Fluocinonide—Betamethasone—rheumatoid arthritis	0.000809	0.156	CbGdCrCtD
Tafluprost—PTGS2—Fluocinonide—Triamcinolone—rheumatoid arthritis	0.000791	0.153	CbGdCrCtD
Tafluprost—Conjunctival hyperaemia—Betamethasone—rheumatoid arthritis	0.000685	0.032	CcSEcCtD
Tafluprost—Conjunctival hyperaemia—Dexamethasone—rheumatoid arthritis	0.000685	0.032	CcSEcCtD
Tafluprost—Asthma—Penicillamine—rheumatoid arthritis	0.000656	0.0306	CcSEcCtD
Tafluprost—Endophthalmitis—Dexamethasone—rheumatoid arthritis	0.000633	0.0295	CcSEcCtD
Tafluprost—Endophthalmitis—Betamethasone—rheumatoid arthritis	0.000633	0.0295	CcSEcCtD
Tafluprost—Endophthalmitis—Prednisone—rheumatoid arthritis	0.000551	0.0257	CcSEcCtD
Tafluprost—Cataract—Leflunomide—rheumatoid arthritis	0.00054	0.0252	CcSEcCtD
Tafluprost—Eye disorder—Auranofin—rheumatoid arthritis	0.000531	0.0248	CcSEcCtD
Tafluprost—Visual acuity reduced—Dexamethasone—rheumatoid arthritis	0.000506	0.0236	CcSEcCtD
Tafluprost—Visual acuity reduced—Betamethasone—rheumatoid arthritis	0.000506	0.0236	CcSEcCtD
Tafluprost—PTGS2—Fluticasone Propionate—Methylprednisolone—rheumatoid arthritis	0.000496	0.0957	CbGdCrCtD
Tafluprost—PTGS2—Fluticasone Propionate—Betamethasone—rheumatoid arthritis	0.000488	0.0942	CbGdCrCtD
Tafluprost—PTGS2—Fluticasone Propionate—Dexamethasone—rheumatoid arthritis	0.000488	0.0942	CbGdCrCtD
Tafluprost—PTGS2—Fluticasone Propionate—Triamcinolone—rheumatoid arthritis	0.000477	0.0921	CbGdCrCtD
Tafluprost—Lacrimation increased—Cyclosporine—rheumatoid arthritis	0.000431	0.0201	CcSEcCtD
Tafluprost—Eye irritation—Prednisolone—rheumatoid arthritis	0.000423	0.0197	CcSEcCtD
Tafluprost—Cataract—Cyclosporine—rheumatoid arthritis	0.000417	0.0195	CcSEcCtD
Tafluprost—Cataract—Hydrocortisone—rheumatoid arthritis	0.00037	0.0173	CcSEcCtD
Tafluprost—Cataract—Triamcinolone—rheumatoid arthritis	0.000349	0.0163	CcSEcCtD
Tafluprost—Dry eye—Hydrocortisone—rheumatoid arthritis	0.000326	0.0152	CcSEcCtD
Tafluprost—Asthma—Leflunomide—rheumatoid arthritis	0.000323	0.0151	CcSEcCtD
Tafluprost—Eye pain—Cyclosporine—rheumatoid arthritis	0.000319	0.0149	CcSEcCtD
Tafluprost—Cataract—Dexamethasone—rheumatoid arthritis	0.000316	0.0148	CcSEcCtD
Tafluprost—Cataract—Betamethasone—rheumatoid arthritis	0.000316	0.0148	CcSEcCtD
Tafluprost—Pruritus—Auranofin—rheumatoid arthritis	0.000286	0.0133	CcSEcCtD
Tafluprost—Urinary tract infection—Leflunomide—rheumatoid arthritis	0.00028	0.0131	CcSEcCtD
Tafluprost—Dry eye—Dexamethasone—rheumatoid arthritis	0.000278	0.013	CcSEcCtD
Tafluprost—Dry eye—Betamethasone—rheumatoid arthritis	0.000278	0.013	CcSEcCtD
Tafluprost—Cataract—Prednisone—rheumatoid arthritis	0.000276	0.0129	CcSEcCtD
Tafluprost—PTGS2—Calcium signaling in the CD4+ TCR pathway—IFNG—rheumatoid arthritis	0.000262	0.00376	CbGpPWpGaD
Tafluprost—PTGS2—Spinal Cord Injury—C5—rheumatoid arthritis	0.000262	0.00376	CbGpPWpGaD
Tafluprost—PTGS2—C-MYB transcription factor network—CDK6—rheumatoid arthritis	0.00026	0.00374	CbGpPWpGaD
Tafluprost—Rhinitis—Leflunomide—rheumatoid arthritis	0.000259	0.0121	CcSEcCtD
Tafluprost—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL2RA—rheumatoid arthritis	0.000257	0.00369	CbGpPWpGaD
Tafluprost—PTGFR—GPCR downstream signaling—PDE2A—rheumatoid arthritis	0.000246	0.00353	CbGpPWpGaD
Tafluprost—Eye pain—Betamethasone—rheumatoid arthritis	0.000242	0.0113	CcSEcCtD
Tafluprost—Eye pain—Dexamethasone—rheumatoid arthritis	0.000242	0.0113	CcSEcCtD
Tafluprost—Eye disorder—Leflunomide—rheumatoid arthritis	0.000241	0.0113	CcSEcCtD
Tafluprost—PTGFR—GPCR ligand binding—CXCL2—rheumatoid arthritis	0.000241	0.00346	CbGpPWpGaD
Tafluprost—PTGFR—GPCR ligand binding—CCL3—rheumatoid arthritis	0.000241	0.00346	CbGpPWpGaD
Tafluprost—PTGS2—Overview of nanoparticle effects—TNF—rheumatoid arthritis	0.000238	0.00342	CbGpPWpGaD
Tafluprost—PTGFR—Class A/1 (Rhodopsin-like receptors)—CXCL10—rheumatoid arthritis	0.000238	0.00341	CbGpPWpGaD
Tafluprost—PTGFR—GPCR ligand binding—SAA1—rheumatoid arthritis	0.000235	0.00338	CbGpPWpGaD
Tafluprost—PTGS2—Spinal Cord Injury—FCGR2A—rheumatoid arthritis	0.000235	0.00337	CbGpPWpGaD
Tafluprost—PTGS2—Calcium signaling in the CD4+ TCR pathway—IL2—rheumatoid arthritis	0.000233	0.00335	CbGpPWpGaD
Tafluprost—PTGS2—Spinal Cord Injury—CXCL2—rheumatoid arthritis	0.000225	0.00323	CbGpPWpGaD
Tafluprost—PTGFR—Signaling by GPCR—PDE2A—rheumatoid arthritis	0.000223	0.0032	CbGpPWpGaD
Tafluprost—Urinary tract infection—Cyclosporine—rheumatoid arthritis	0.000216	0.0101	CcSEcCtD
Tafluprost—PTGFR—GPCRs, Class A Rhodopsin-like—CCR5—rheumatoid arthritis	0.000215	0.00309	CbGpPWpGaD
Tafluprost—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—IL6ST—rheumatoid arthritis	0.000213	0.00305	CbGpPWpGaD
Tafluprost—Vision blurred—Leflunomide—rheumatoid arthritis	0.000212	0.00989	CcSEcCtD
Tafluprost—Asthma—Triamcinolone—rheumatoid arthritis	0.000208	0.00972	CcSEcCtD
Tafluprost—PTGFR—GPCR ligand binding—BDKRB2—rheumatoid arthritis	0.000205	0.00294	CbGpPWpGaD
Tafluprost—PTGFR—GPCR ligand binding—CXCL12—rheumatoid arthritis	0.000205	0.00294	CbGpPWpGaD
Tafluprost—PTGFR—Class A/1 (Rhodopsin-like receptors)—CCL5—rheumatoid arthritis	0.000204	0.00294	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism of lipids and lipoproteins—FADS2—rheumatoid arthritis	0.000201	0.00289	CbGpPWpGaD
Tafluprost—Rhinitis—Cyclosporine—rheumatoid arthritis	0.0002	0.00933	CcSEcCtD
Tafluprost—Cough—Leflunomide—rheumatoid arthritis	0.000196	0.00916	CcSEcCtD
Tafluprost—PTGS2—Selenium Micronutrient Network—CAT—rheumatoid arthritis	0.000194	0.00279	CbGpPWpGaD
Tafluprost—PTGS2—Overview of nanoparticle effects—IL6—rheumatoid arthritis	0.000192	0.00276	CbGpPWpGaD
Tafluprost—PTGFR—GPCR downstream signaling—CXCL13—rheumatoid arthritis	0.000191	0.00274	CbGpPWpGaD
Tafluprost—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—IL6R—rheumatoid arthritis	0.00019	0.00272	CbGpPWpGaD
Tafluprost—PTGFR—Class A/1 (Rhodopsin-like receptors)—CCR5—rheumatoid arthritis	0.000184	0.00265	CbGpPWpGaD
Tafluprost—PTGS2—Selenium Micronutrient Network—SOD2—rheumatoid arthritis	0.000184	0.00264	CbGpPWpGaD
Tafluprost—PTGFR—GPCR ligand binding—CXCL10—rheumatoid arthritis	0.000181	0.0026	CbGpPWpGaD
Tafluprost—PTGFR—Class A/1 (Rhodopsin-like receptors)—C3—rheumatoid arthritis	0.00018	0.00259	CbGpPWpGaD
Tafluprost—Nervous system disorder—Leflunomide—rheumatoid arthritis	0.00018	0.0084	CcSEcCtD
Tafluprost—PTGFR—Signaling Pathways—CXCL6—rheumatoid arthritis	0.000174	0.0025	CbGpPWpGaD
Tafluprost—PTGFR—Signaling by GPCR—CXCL13—rheumatoid arthritis	0.000173	0.00249	CbGpPWpGaD
Tafluprost—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—TYK2—rheumatoid arthritis	0.000173	0.00248	CbGpPWpGaD
Tafluprost—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IFNG—rheumatoid arthritis	0.00017	0.00243	CbGpPWpGaD
Tafluprost—PTGS2—Spinal Cord Injury—CXCL10—rheumatoid arthritis	0.000169	0.00243	CbGpPWpGaD
Tafluprost—Rhinitis—Triamcinolone—rheumatoid arthritis	0.000167	0.0078	CcSEcCtD
Tafluprost—Rhinitis—Methylprednisolone—rheumatoid arthritis	0.000167	0.00779	CcSEcCtD
Tafluprost—PTGFR—Signaling Pathways—CCL21—rheumatoid arthritis	0.000166	0.00238	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—SYVN1—rheumatoid arthritis	0.000166	0.00238	CbGpPWpGaD
Tafluprost—Eye disorder—Hydrocortisone—rheumatoid arthritis	0.000165	0.00773	CcSEcCtD
Tafluprost—PTGFR—GPCR downstream signaling—IL2RB—rheumatoid arthritis	0.000164	0.00235	CbGpPWpGaD
Tafluprost—PTGS2—Defective AMN causes hereditary megaloblastic anemia 1—MTHFR—rheumatoid arthritis	0.000164	0.00235	CbGpPWpGaD
Tafluprost—Dyspnoea—Leflunomide—rheumatoid arthritis	0.000164	0.00763	CcSEcCtD
Tafluprost—Vision blurred—Cyclosporine—rheumatoid arthritis	0.000163	0.00763	CcSEcCtD
Tafluprost—PTGS2—Selenium Micronutrient Network—MTHFR—rheumatoid arthritis	0.000162	0.00233	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—TAGAP—rheumatoid arthritis	0.000159	0.00228	CbGpPWpGaD
Tafluprost—PTGFR—GPCR downstream signaling—C5—rheumatoid arthritis	0.000158	0.00227	CbGpPWpGaD
Tafluprost—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CXCL8—rheumatoid arthritis	0.000158	0.00226	CbGpPWpGaD
Tafluprost—PTGFR—GPCR ligand binding—CCL5—rheumatoid arthritis	0.000156	0.00224	CbGpPWpGaD
Tafluprost—Eye disorder—Methylprednisolone—rheumatoid arthritis	0.000155	0.00726	CcSEcCtD
Tafluprost—PTGFR—Signaling by GPCR—CX3CR1—rheumatoid arthritis	0.000155	0.00222	CbGpPWpGaD
Tafluprost—PTGS2—Selenium Micronutrient Network—CRP—rheumatoid arthritis	0.000154	0.00221	CbGpPWpGaD
Tafluprost—Cough—Cyclosporine—rheumatoid arthritis	0.000151	0.00707	CcSEcCtD
Tafluprost—PTGS2—Aryl Hydrocarbon Receptor—NFKB1—rheumatoid arthritis	0.000151	0.00217	CbGpPWpGaD
Tafluprost—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL2—rheumatoid arthritis	0.000151	0.00216	CbGpPWpGaD
Tafluprost—PTGFR—Signaling by GPCR—IL2RB—rheumatoid arthritis	0.000149	0.00214	CbGpPWpGaD
Tafluprost—Vision blurred—Prednisolone—rheumatoid arthritis	0.000149	0.00694	CcSEcCtD
Tafluprost—PTGFR—GPCR downstream signaling—CCR6—rheumatoid arthritis	0.000149	0.00214	CbGpPWpGaD
Tafluprost—PTGS2—Spinal Cord Injury—IL1A—rheumatoid arthritis	0.000146	0.0021	CbGpPWpGaD
Tafluprost—PTGFR—Class A/1 (Rhodopsin-like receptors)—POMC—rheumatoid arthritis	0.000144	0.00207	CbGpPWpGaD
Tafluprost—PTGFR—Signaling by GPCR—C5—rheumatoid arthritis	0.000144	0.00206	CbGpPWpGaD
Tafluprost—PTGS2—Selenium Micronutrient Network—ICAM1—rheumatoid arthritis	0.000142	0.00204	CbGpPWpGaD
Tafluprost—Eye disorder—Dexamethasone—rheumatoid arthritis	0.000141	0.0066	CcSEcCtD
Tafluprost—Eye disorder—Betamethasone—rheumatoid arthritis	0.000141	0.0066	CcSEcCtD
Tafluprost—PTGS2—Spinal Cord Injury—IL4—rheumatoid arthritis	0.000141	0.00203	CbGpPWpGaD
Tafluprost—PTGFR—Class A/1 (Rhodopsin-like receptors)—CCL2—rheumatoid arthritis	0.000141	0.00202	CbGpPWpGaD
Tafluprost—PTGFR—GPCR ligand binding—CCR5—rheumatoid arthritis	0.00014	0.00201	CbGpPWpGaD
Tafluprost—Nervous system disorder—Cyclosporine—rheumatoid arthritis	0.000139	0.00648	CcSEcCtD
Tafluprost—Asthma—Methotrexate—rheumatoid arthritis	0.000138	0.00642	CcSEcCtD
Tafluprost—PTGFR—GPCR ligand binding—C3—rheumatoid arthritis	0.000137	0.00197	CbGpPWpGaD
Tafluprost—PTGS2—Aryl Hydrocarbon Receptor—VEGFA—rheumatoid arthritis	0.000137	0.00197	CbGpPWpGaD
Tafluprost—PTGFR—GPCR downstream signaling—CXCL2—rheumatoid arthritis	0.000136	0.00195	CbGpPWpGaD
Tafluprost—PTGFR—Signaling by GPCR—CCR6—rheumatoid arthritis	0.000135	0.00194	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism of lipids and lipoproteins—PLD4—rheumatoid arthritis	0.000134	0.00193	CbGpPWpGaD
Tafluprost—PTGFR—GPCR downstream signaling—SAA1—rheumatoid arthritis	0.000133	0.00191	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—PDE2A—rheumatoid arthritis	0.000132	0.00189	CbGpPWpGaD
Tafluprost—Pruritus—Leflunomide—rheumatoid arthritis	0.00013	0.00606	CcSEcCtD
Tafluprost—PTGS2—Integrated Pancreatic Cancer Pathway—TNFRSF1A—rheumatoid arthritis	0.000129	0.00185	CbGpPWpGaD
Tafluprost—PTGS2—Signaling mediated by p38-alpha and p38-beta—TP53—rheumatoid arthritis	0.000129	0.00185	CbGpPWpGaD
Tafluprost—PTGS2—Selenium Micronutrient Network—CCL2—rheumatoid arthritis	0.000127	0.00182	CbGpPWpGaD
Tafluprost—Cough—Triamcinolone—rheumatoid arthritis	0.000127	0.00591	CcSEcCtD
Tafluprost—Dyspnoea—Cyclosporine—rheumatoid arthritis	0.000126	0.00589	CcSEcCtD
Tafluprost—PTGFR—Signaling Pathways—PLB1—rheumatoid arthritis	0.000126	0.0018	CbGpPWpGaD
Tafluprost—PTGFR—Signaling by GPCR—CCL3—rheumatoid arthritis	0.000124	0.00177	CbGpPWpGaD
Tafluprost—PTGFR—Signaling by GPCR—CXCL2—rheumatoid arthritis	0.000124	0.00177	CbGpPWpGaD
Tafluprost—Nervous system disorder—Hydrocortisone—rheumatoid arthritis	0.000123	0.00576	CcSEcCtD
Tafluprost—Eye disorder—Prednisone—rheumatoid arthritis	0.000123	0.00575	CcSEcCtD
Tafluprost—Headache—Azathioprine—rheumatoid arthritis	0.000122	0.00568	CcSEcCtD
Tafluprost—PTGFR—Signaling by GPCR—SAA1—rheumatoid arthritis	0.000121	0.00173	CbGpPWpGaD
Tafluprost—PTGS2—Spinal Cord Injury—LEP—rheumatoid arthritis	0.000119	0.00171	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism of lipids and lipoproteins—PTGES—rheumatoid arthritis	0.000118	0.0017	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism of lipids and lipoproteins—GC—rheumatoid arthritis	0.000118	0.0017	CbGpPWpGaD
Tafluprost—PTGS2—Selenium Micronutrient Network—ALB—rheumatoid arthritis	0.000118	0.0017	CbGpPWpGaD
Tafluprost—PTGS2—Aryl Hydrocarbon Receptor—TNF—rheumatoid arthritis	0.000117	0.00168	CbGpPWpGaD
Tafluprost—PTGS2—Spinal Cord Injury—TLR4—rheumatoid arthritis	0.000117	0.00168	CbGpPWpGaD
Tafluprost—PTGS2—Integrated Pancreatic Cancer Pathway—STAT1—rheumatoid arthritis	0.000117	0.00168	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—RBPJ—rheumatoid arthritis	0.000116	0.00166	CbGpPWpGaD
Tafluprost—Nervous system disorder—Methylprednisolone—rheumatoid arthritis	0.000116	0.00541	CcSEcCtD
Tafluprost—PTGFR—GPCR downstream signaling—CXCL12—rheumatoid arthritis	0.000116	0.00166	CbGpPWpGaD
Tafluprost—PTGFR—GPCR downstream signaling—BDKRB2—rheumatoid arthritis	0.000116	0.00166	CbGpPWpGaD
Tafluprost—Headache—Leflunomide—rheumatoid arthritis	0.000115	0.00536	CcSEcCtD
Tafluprost—PTGFR—GPCR downstream signaling—ADRBK1—rheumatoid arthritis	0.000114	0.00164	CbGpPWpGaD
Tafluprost—PTGS2—Spinal Cord Injury—ICAM1—rheumatoid arthritis	0.000112	0.00161	CbGpPWpGaD
Tafluprost—PTGFR—Class A/1 (Rhodopsin-like receptors)—CXCL8—rheumatoid arthritis	0.000111	0.0016	CbGpPWpGaD
Tafluprost—PTGS2—Spinal Cord Injury—NOS2—rheumatoid arthritis	0.000111	0.0016	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism of lipids and lipoproteins—PLB1—rheumatoid arthritis	0.00011	0.00158	CbGpPWpGaD
Tafluprost—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—rheumatoid arthritis	0.00011	0.00158	CbGpPWpGaD
Tafluprost—PTGFR—GPCR ligand binding—POMC—rheumatoid arthritis	0.00011	0.00157	CbGpPWpGaD
Tafluprost—PTGS2—C-MYB transcription factor network—CD4—rheumatoid arthritis	0.000108	0.00155	CbGpPWpGaD
Tafluprost—Vision blurred—Prednisone—rheumatoid arthritis	0.000108	0.00505	CcSEcCtD
Tafluprost—PTGFR—GPCR downstream signaling—RASGRP1—rheumatoid arthritis	0.000108	0.00155	CbGpPWpGaD
Tafluprost—PTGS2—Selenium Micronutrient Network—IFNG—rheumatoid arthritis	0.000108	0.00155	CbGpPWpGaD
Tafluprost—PTGFR—GPCR ligand binding—CCL2—rheumatoid arthritis	0.000107	0.00154	CbGpPWpGaD
Tafluprost—Dyspnoea—Triamcinolone—rheumatoid arthritis	0.000106	0.00493	CcSEcCtD
Tafluprost—PTGFR—GPCR downstream signaling—PRKCQ—rheumatoid arthritis	0.000106	0.00152	CbGpPWpGaD
Tafluprost—Nervous system disorder—Dexamethasone—rheumatoid arthritis	0.000105	0.00492	CcSEcCtD
Tafluprost—Nervous system disorder—Betamethasone—rheumatoid arthritis	0.000105	0.00492	CcSEcCtD
Tafluprost—PTGFR—Signaling by GPCR—BDKRB2—rheumatoid arthritis	0.000105	0.00151	CbGpPWpGaD
Tafluprost—PTGFR—Signaling by GPCR—CXCL12—rheumatoid arthritis	0.000105	0.00151	CbGpPWpGaD
Tafluprost—PTGFR—Signaling by GPCR—ADRBK1—rheumatoid arthritis	0.000104	0.00149	CbGpPWpGaD
Tafluprost—Eye disorder—Methotrexate—rheumatoid arthritis	0.000103	0.0048	CcSEcCtD
Tafluprost—PTGFR—Signaling Pathways—CXCL13—rheumatoid arthritis	0.000102	0.00147	CbGpPWpGaD
Tafluprost—PTGFR—GPCR downstream signaling—CXCL10—rheumatoid arthritis	0.000102	0.00147	CbGpPWpGaD
Tafluprost—PTGS2—Spinal Cord Injury—CCL2—rheumatoid arthritis	0.0001	0.00144	CbGpPWpGaD
Tafluprost—Pruritus—Cyclosporine—rheumatoid arthritis	0.0001	0.00468	CcSEcCtD
Tafluprost—PTGFR—Signaling by GPCR—RASGRP1—rheumatoid arthritis	9.8e-05	0.00141	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism of lipids and lipoproteins—MED1—rheumatoid arthritis	9.65e-05	0.00139	CbGpPWpGaD
Tafluprost—PTGS2—Selenium Micronutrient Network—IL1B—rheumatoid arthritis	9.62e-05	0.00138	CbGpPWpGaD
Tafluprost—PTGFR—Signaling by GPCR—PRKCQ—rheumatoid arthritis	9.59e-05	0.00138	CbGpPWpGaD
Tafluprost—PTGFR—Signaling by GPCR—CXCL10—rheumatoid arthritis	9.28e-05	0.00133	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—TLE3—rheumatoid arthritis	9.22e-05	0.00132	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—IRAK1—rheumatoid arthritis	9.22e-05	0.00132	CbGpPWpGaD
Tafluprost—Nervous system disorder—Prednisone—rheumatoid arthritis	9.18e-05	0.00429	CcSEcCtD
Tafluprost—PTGS2—Integrated Pancreatic Cancer Pathway—FASLG—rheumatoid arthritis	9.17e-05	0.00132	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—CX3CR1—rheumatoid arthritis	9.13e-05	0.00131	CbGpPWpGaD
Tafluprost—Vision blurred—Methotrexate—rheumatoid arthritis	9.03e-05	0.00422	CcSEcCtD
Tafluprost—PTGS2—Selenium Micronutrient Network—NFKB1—rheumatoid arthritis	8.98e-05	0.00129	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—FADS2—rheumatoid arthritis	8.95e-05	0.00128	CbGpPWpGaD
Tafluprost—Pruritus—Hydrocortisone—rheumatoid arthritis	8.9e-05	0.00416	CcSEcCtD
Tafluprost—Headache—Cyclosporine—rheumatoid arthritis	8.87e-05	0.00414	CcSEcCtD
Tafluprost—PTGS2—Integrated Pancreatic Cancer Pathway—FAS—rheumatoid arthritis	8.85e-05	0.00127	CbGpPWpGaD
Tafluprost—PTGFR—GPCR downstream signaling—CCL5—rheumatoid arthritis	8.8e-05	0.00126	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—IL2RB—rheumatoid arthritis	8.79e-05	0.00126	CbGpPWpGaD
Tafluprost—PTGFR—GPCR downstream signaling—CSF2—rheumatoid arthritis	8.67e-05	0.00124	CbGpPWpGaD
Tafluprost—PTGS2—Spinal Cord Injury—IFNG—rheumatoid arthritis	8.53e-05	0.00122	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—C5—rheumatoid arthritis	8.49e-05	0.00122	CbGpPWpGaD
Tafluprost—PTGFR—GPCR ligand binding—CXCL8—rheumatoid arthritis	8.48e-05	0.00122	CbGpPWpGaD
Tafluprost—PTGFR—Signaling by GPCR—MMP3—rheumatoid arthritis	8.47e-05	0.00122	CbGpPWpGaD
Tafluprost—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—rheumatoid arthritis	8.45e-05	0.00121	CbGpPWpGaD
Tafluprost—Pruritus—Triamcinolone—rheumatoid arthritis	8.38e-05	0.00391	CcSEcCtD
Tafluprost—Cough—Methotrexate—rheumatoid arthritis	8.36e-05	0.0039	CcSEcCtD
Tafluprost—Pruritus—Methylprednisolone—rheumatoid arthritis	8.36e-05	0.0039	CcSEcCtD
Tafluprost—PTGFR—Signaling Pathways—NFATC1—rheumatoid arthritis	8.35e-05	0.0012	CbGpPWpGaD
Tafluprost—Headache—Prednisolone—rheumatoid arthritis	8.07e-05	0.00377	CcSEcCtD
Tafluprost—PTGFR—Signaling by GPCR—CCL5—rheumatoid arthritis	7.99e-05	0.00115	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—CCR6—rheumatoid arthritis	7.98e-05	0.00115	CbGpPWpGaD
Tafluprost—PTGS2—Spinal Cord Injury—CXCL8—rheumatoid arthritis	7.93e-05	0.00114	CbGpPWpGaD
Tafluprost—PTGFR—GPCR downstream signaling—CCR5—rheumatoid arthritis	7.93e-05	0.00114	CbGpPWpGaD
Tafluprost—Headache—Hydrocortisone—rheumatoid arthritis	7.88e-05	0.00368	CcSEcCtD
Tafluprost—PTGFR—Signaling by GPCR—CSF2—rheumatoid arthritis	7.87e-05	0.00113	CbGpPWpGaD
Tafluprost—PTGFR—GPCR downstream signaling—IL2RA—rheumatoid arthritis	7.81e-05	0.00112	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—NCF2—rheumatoid arthritis	7.76e-05	0.00111	CbGpPWpGaD
Tafluprost—PTGFR—GPCR downstream signaling—C3—rheumatoid arthritis	7.75e-05	0.00111	CbGpPWpGaD
Tafluprost—PTGS2—Disease—SYVN1—rheumatoid arthritis	7.73e-05	0.00111	CbGpPWpGaD
Tafluprost—Nervous system disorder—Methotrexate—rheumatoid arthritis	7.67e-05	0.00358	CcSEcCtD
Tafluprost—PTGS2—Spinal Cord Injury—IL1B—rheumatoid arthritis	7.61e-05	0.00109	CbGpPWpGaD
Tafluprost—Pruritus—Dexamethasone—rheumatoid arthritis	7.6e-05	0.00355	CcSEcCtD
Tafluprost—Pruritus—Betamethasone—rheumatoid arthritis	7.6e-05	0.00355	CcSEcCtD
Tafluprost—PTGS2—Spinal Cord Injury—IL2—rheumatoid arthritis	7.58e-05	0.00109	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—TRAF6—rheumatoid arthritis	7.56e-05	0.00109	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—SH2B3—rheumatoid arthritis	7.56e-05	0.00109	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—GZMB—rheumatoid arthritis	7.52e-05	0.00108	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism of lipids and lipoproteins—ALOX5—rheumatoid arthritis	7.44e-05	0.00107	CbGpPWpGaD
Tafluprost—Headache—Triamcinolone—rheumatoid arthritis	7.42e-05	0.00346	CcSEcCtD
Tafluprost—Headache—Methylprednisolone—rheumatoid arthritis	7.4e-05	0.00346	CcSEcCtD
Tafluprost—PTGFR—Signaling Pathways—CCL3—rheumatoid arthritis	7.3e-05	0.00105	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—CXCL2—rheumatoid arthritis	7.3e-05	0.00105	CbGpPWpGaD
Tafluprost—PTGFR—Signaling by GPCR—CCR5—rheumatoid arthritis	7.2e-05	0.00103	CbGpPWpGaD
Tafluprost—PTGS2—Spinal Cord Injury—MMP9—rheumatoid arthritis	7.17e-05	0.00103	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—SAA1—rheumatoid arthritis	7.14e-05	0.00102	CbGpPWpGaD
Tafluprost—PTGFR—Signaling by GPCR—IL2RA—rheumatoid arthritis	7.1e-05	0.00102	CbGpPWpGaD
Tafluprost—PTGFR—Signaling by GPCR—C3—rheumatoid arthritis	7.04e-05	0.00101	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—NCF1—rheumatoid arthritis	6.99e-05	0.001	CbGpPWpGaD
Tafluprost—PTGS2—Selenium Micronutrient Network—TNF—rheumatoid arthritis	6.98e-05	0.001	CbGpPWpGaD
Tafluprost—Dyspnoea—Methotrexate—rheumatoid arthritis	6.97e-05	0.00326	CcSEcCtD
Tafluprost—PTGS2—Disease—ACAN—rheumatoid arthritis	6.89e-05	0.000989	CbGpPWpGaD
Tafluprost—Headache—Betamethasone—rheumatoid arthritis	6.73e-05	0.00314	CcSEcCtD
Tafluprost—Headache—Dexamethasone—rheumatoid arthritis	6.73e-05	0.00314	CcSEcCtD
Tafluprost—PTGFR—Signaling Pathways—CD28—rheumatoid arthritis	6.72e-05	0.000965	CbGpPWpGaD
Tafluprost—Pruritus—Prednisone—rheumatoid arthritis	6.62e-05	0.00309	CcSEcCtD
Tafluprost—PTGS2—Disease—SLC25A12—rheumatoid arthritis	6.47e-05	0.00093	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—UBE2D1—rheumatoid arthritis	6.33e-05	0.000909	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—CXCL12—rheumatoid arthritis	6.21e-05	0.000891	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—BDKRB2—rheumatoid arthritis	6.21e-05	0.000891	CbGpPWpGaD
Tafluprost—PTGFR—GPCR downstream signaling—POMC—rheumatoid arthritis	6.2e-05	0.00089	CbGpPWpGaD
Tafluprost—PTGFR—Signaling by GPCR—IL6ST—rheumatoid arthritis	6.15e-05	0.000883	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—ADRBK1—rheumatoid arthritis	6.14e-05	0.000881	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—PLD4—rheumatoid arthritis	5.97e-05	0.000857	CbGpPWpGaD
Tafluprost—PTGS2—Spinal Cord Injury—TGFB1—rheumatoid arthritis	5.91e-05	0.000849	CbGpPWpGaD
Tafluprost—Headache—Prednisone—rheumatoid arthritis	5.86e-05	0.00274	CcSEcCtD
Tafluprost—PTGS2—Disease—PLB1—rheumatoid arthritis	5.85e-05	0.000841	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—RASGRP1—rheumatoid arthritis	5.79e-05	0.000831	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—SYK—rheumatoid arthritis	5.77e-05	0.000828	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—ACAN—rheumatoid arthritis	5.77e-05	0.000828	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—PRKCQ—rheumatoid arthritis	5.66e-05	0.000813	CbGpPWpGaD
Tafluprost—PTGS2—Selenium Micronutrient Network—IL6—rheumatoid arthritis	5.63e-05	0.000809	CbGpPWpGaD
Tafluprost—PTGFR—Signaling by GPCR—POMC—rheumatoid arthritis	5.63e-05	0.000808	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—STAT1—rheumatoid arthritis	5.56e-05	0.000799	CbGpPWpGaD
Tafluprost—Pruritus—Methotrexate—rheumatoid arthritis	5.53e-05	0.00258	CcSEcCtD
Tafluprost—PTGS2—Spinal Cord Injury—TNF—rheumatoid arthritis	5.52e-05	0.000793	CbGpPWpGaD
Tafluprost—PTGFR—Signaling by GPCR—CCL2—rheumatoid arthritis	5.51e-05	0.000791	CbGpPWpGaD
Tafluprost—PTGFR—Signaling by GPCR—IL6R—rheumatoid arthritis	5.49e-05	0.000788	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—CXCL10—rheumatoid arthritis	5.48e-05	0.000787	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—SLC25A12—rheumatoid arthritis	5.42e-05	0.000778	CbGpPWpGaD
Tafluprost—PTGS2—Disease—RBPJ—rheumatoid arthritis	5.4e-05	0.000776	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—PTGES—rheumatoid arthritis	5.27e-05	0.000757	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—GC—rheumatoid arthritis	5.27e-05	0.000757	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—MMP3—rheumatoid arthritis	5e-05	0.000718	CbGpPWpGaD
Tafluprost—PTGFR—Signaling by GPCR—TYK2—rheumatoid arthritis	5e-05	0.000718	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—PLB1—rheumatoid arthritis	4.9e-05	0.000704	CbGpPWpGaD
Tafluprost—Headache—Methotrexate—rheumatoid arthritis	4.9e-05	0.00229	CcSEcCtD
Tafluprost—PTGS2—Spinal Cord Injury—TP53—rheumatoid arthritis	4.87e-05	0.000699	CbGpPWpGaD
Tafluprost—PTGS2—Integrated Pancreatic Cancer Pathway—NFKB1—rheumatoid arthritis	4.83e-05	0.000693	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—PTK2—rheumatoid arthritis	4.81e-05	0.000691	CbGpPWpGaD
Tafluprost—PTGFR—GPCR downstream signaling—CXCL8—rheumatoid arthritis	4.79e-05	0.000688	CbGpPWpGaD
Tafluprost—PTGS2—Disease—ACP5—rheumatoid arthritis	4.77e-05	0.000685	CbGpPWpGaD
Tafluprost—PTGS2—Disease—B3GNT2—rheumatoid arthritis	4.77e-05	0.000685	CbGpPWpGaD
Tafluprost—PTGS2—Integrated Pancreatic Cancer Pathway—MAPK8—rheumatoid arthritis	4.75e-05	0.000682	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—CCL5—rheumatoid arthritis	4.72e-05	0.000678	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—CSF2—rheumatoid arthritis	4.65e-05	0.000668	CbGpPWpGaD
Tafluprost—PTGFR—GPCR downstream signaling—IL2—rheumatoid arthritis	4.58e-05	0.000658	CbGpPWpGaD
Tafluprost—PTGS2—Spinal Cord Injury—IL6—rheumatoid arthritis	4.46e-05	0.00064	CbGpPWpGaD
Tafluprost—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—rheumatoid arthritis	4.38e-05	0.000629	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—SPP1—rheumatoid arthritis	4.37e-05	0.000628	CbGpPWpGaD
Tafluprost—PTGFR—Signaling by GPCR—CXCL8—rheumatoid arthritis	4.35e-05	0.000625	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—MED1—rheumatoid arthritis	4.3e-05	0.000617	CbGpPWpGaD
Tafluprost—PTGS2—Disease—BGN—rheumatoid arthritis	4.3e-05	0.000617	CbGpPWpGaD
Tafluprost—PTGS2—Disease—TLE3—rheumatoid arthritis	4.3e-05	0.000617	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—CCR5—rheumatoid arthritis	4.25e-05	0.000611	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—IL2RA—rheumatoid arthritis	4.19e-05	0.000602	CbGpPWpGaD
Tafluprost—PTGFR—Signaling by GPCR—IL2—rheumatoid arthritis	4.16e-05	0.000597	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—C3—rheumatoid arthritis	4.16e-05	0.000597	CbGpPWpGaD
Tafluprost—PTGS2—Integrated Pancreatic Cancer Pathway—TGFB1—rheumatoid arthritis	4.02e-05	0.000578	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—B3GNT2—rheumatoid arthritis	4e-05	0.000574	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—ACP5—rheumatoid arthritis	4e-05	0.000574	CbGpPWpGaD
Tafluprost—PTGS2—Disease—SLC11A1—rheumatoid arthritis	3.92e-05	0.000563	CbGpPWpGaD
Tafluprost—PTGS2—Disease—NFATC1—rheumatoid arthritis	3.89e-05	0.000559	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—LEP—rheumatoid arthritis	3.87e-05	0.000556	CbGpPWpGaD
Tafluprost—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—rheumatoid arthritis	3.76e-05	0.000539	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—FN1—rheumatoid arthritis	3.65e-05	0.000524	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—IL6ST—rheumatoid arthritis	3.63e-05	0.000522	CbGpPWpGaD
Tafluprost—PTGS2—Disease—NCF2—rheumatoid arthritis	3.62e-05	0.000519	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—BGN—rheumatoid arthritis	3.6e-05	0.000517	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—CD80—rheumatoid arthritis	3.5e-05	0.000502	CbGpPWpGaD
Tafluprost—PTGS2—Disease—SAA1—rheumatoid arthritis	3.33e-05	0.000478	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—POMC—rheumatoid arthritis	3.32e-05	0.000477	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—ALOX5—rheumatoid arthritis	3.31e-05	0.000476	CbGpPWpGaD
Tafluprost—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—rheumatoid arthritis	3.31e-05	0.000475	CbGpPWpGaD
Tafluprost—PTGS2—Disease—NCF1—rheumatoid arthritis	3.26e-05	0.000468	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—CCL2—rheumatoid arthritis	3.25e-05	0.000467	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—IL6R—rheumatoid arthritis	3.24e-05	0.000466	CbGpPWpGaD
Tafluprost—PTGS2—Disease—ENO1—rheumatoid arthritis	3.22e-05	0.000463	CbGpPWpGaD
Tafluprost—PTGS2—Disease—CD28—rheumatoid arthritis	3.13e-05	0.00045	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—TYK2—rheumatoid arthritis	2.95e-05	0.000424	CbGpPWpGaD
Tafluprost—PTGS2—Disease—UBE2D1—rheumatoid arthritis	2.95e-05	0.000423	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism of lipids and lipoproteins—POMC—rheumatoid arthritis	2.91e-05	0.000418	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—NOS3—rheumatoid arthritis	2.9e-05	0.000416	CbGpPWpGaD
Tafluprost—PTGS2—Disease—ADRBK1—rheumatoid arthritis	2.86e-05	0.000411	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—ENO1—rheumatoid arthritis	2.7e-05	0.000388	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism of lipids and lipoproteins—ALB—rheumatoid arthritis	2.66e-05	0.000381	CbGpPWpGaD
Tafluprost—PTGS2—Disease—PRKCQ—rheumatoid arthritis	2.64e-05	0.000379	CbGpPWpGaD
Tafluprost—PTGS2—Disease—STAT1—rheumatoid arthritis	2.59e-05	0.000372	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—CXCL8—rheumatoid arthritis	2.57e-05	0.000369	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—IL2—rheumatoid arthritis	2.46e-05	0.000353	CbGpPWpGaD
Tafluprost—PTGFR—Signaling by GPCR—IL6—rheumatoid arthritis	2.45e-05	0.000351	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—MMP9—rheumatoid arthritis	2.33e-05	0.000334	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—NFKB1—rheumatoid arthritis	2.3e-05	0.00033	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—MAPK8—rheumatoid arthritis	2.26e-05	0.000325	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—VEGFA—rheumatoid arthritis	2.09e-05	0.0003	CbGpPWpGaD
Tafluprost—PTGS2—Disease—CCR5—rheumatoid arthritis	1.98e-05	0.000285	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—CAT—rheumatoid arthritis	1.94e-05	0.000279	CbGpPWpGaD
Tafluprost—PTGS2—Disease—MTHFR—rheumatoid arthritis	1.94e-05	0.000278	CbGpPWpGaD
Tafluprost—PTGS2—Disease—HLA-A—rheumatoid arthritis	1.93e-05	0.000277	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—TGFB1—rheumatoid arthritis	1.92e-05	0.000275	CbGpPWpGaD
Tafluprost—PTGS2—Disease—IL6ST—rheumatoid arthritis	1.69e-05	0.000243	CbGpPWpGaD
Tafluprost—PTGS2—Disease—NOS2—rheumatoid arthritis	1.68e-05	0.000241	CbGpPWpGaD
Tafluprost—PTGS2—Disease—CD80—rheumatoid arthritis	1.63e-05	0.000234	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—MTHFR—rheumatoid arthritis	1.62e-05	0.000233	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—TP53—rheumatoid arthritis	1.58e-05	0.000227	CbGpPWpGaD
Tafluprost—PTGS2—Disease—IL6R—rheumatoid arthritis	1.51e-05	0.000217	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—IL6—rheumatoid arthritis	1.44e-05	0.000207	CbGpPWpGaD
Tafluprost—PTGS2—Disease—TYK2—rheumatoid arthritis	1.38e-05	0.000198	CbGpPWpGaD
Tafluprost—PTGS2—Disease—NOS3—rheumatoid arthritis	1.35e-05	0.000194	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—POMC—rheumatoid arthritis	1.3e-05	0.000186	CbGpPWpGaD
Tafluprost—PTGS2—Disease—CD4—rheumatoid arthritis	1.24e-05	0.000179	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—ALB—rheumatoid arthritis	1.18e-05	0.00017	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—NOS3—rheumatoid arthritis	1.13e-05	0.000162	CbGpPWpGaD
Tafluprost—PTGS2—Disease—TGFB1—rheumatoid arthritis	8.93e-06	0.000128	CbGpPWpGaD
Tafluprost—PTGS2—Disease—IL6—rheumatoid arthritis	6.73e-06	9.66e-05	CbGpPWpGaD
